The Drug Enforcement Administration turned 50 in July 2023, marking five decades and over $1 trillion spent in its unsuccessful attempt to enforce the Controlled Substances Act via what is widely viewed as a failed War on Drugs with a focus on cannabis.
Now, with Friday’s release of documents related to the Department of Health and Human Service’s recommendation to the DEA to remove cannabis from its onerous Schedule I status, one wonders what the DEA will do next.
After all, the DEA recently made it clear that it, and it alone, has the “final authority to schedule, reschedule, or deschedule a drug under the Controlled Substances Act.”
'Abolish The DEA': Julie Holland, M.D., a psychiatrist, MDMA and cannabis researcher and medical advisor to the Multidisciplinary Association for Psychedelic Studies (MAPS), has some advice for the agency.
“This will be the third time, if I’m not mistaken, that there ...